Testing a candidate composite serum protein marker of skin severity in systemic sclerosis.
Elen RoblinKristina E N ClarkClaire BeesleyVoon H OngChristopher P DentonPublished in: Rheumatology advances in practice (2024)
Although more validation is required, our findings represent a further step towards a composite serum protein assay to assess skin severity in SSc. Future work will establish its utility as a predictive or prognostic biomarker.